Literature DB >> 31977320

A Novel Spindle Cell Population in a Case of Primary Osteoma Cutis With GNAS Mutation.

Colleen Beatty1, Zachary Zinn1, Charles Schultz2, Michael C Lynch2.   

Abstract

Primary osteoma cutis is a rare condition belonging to a spectrum of related genetic disorders, including progressive osseous heteroplasia, plate-like osteoma cutis, and Albright hereditary osteodystrophy, which share identical histologies with cutaneous intramembranous ossification and mutations in GNAS. We report a case of a 15-week-old girl who presented with an enlarging, indurated subcutaneous lesion on her right flank. CT scan showed an extensive subcutaneous sheet of calcification. Histologic evaluation revealed heterotopic calcification and intramembranous ossification within the dermis and mature bone largely replacing the subcutaneous fat compatible with osteoma cutis. Molecular testing was performed and identified an inactivating GNAS mutation. Unique to this case is a dermal proliferation of bland spindle cells that blended with deposited osteoid material. This has not been reported in association with primary osteoma cutis previously. These spindle cells were positive for CD44, Bcl-2, muscle-specific actin, and smooth muscle actin while negative for CD34. We hypothesize that these cells are immature mesenchymal cells, representing an early cellular phase of ossification. We favor these cells provide the background in which ossification is occurring, supporting the theory of osteoblastic metaplasia in the etiology of this condition.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31977320      PMCID: PMC7457310          DOI: 10.1097/DAD.0000000000001611

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.319


  9 in total

1.  Cutaneous ossification. Report of 120 cases and review of the literature.

Authors:  S I ROTH; R E STOWELL
Journal:  Arch Pathol       Date:  1963-07

2.  Transforming growth factor beta and connective tissue growth factor are involved in the evolution of nevus of Nanta.

Authors:  Tomoko Keida; Nobukazu Hayashi; Michiko Kawakami; Makoto Kawashima
Journal:  J Dermatol       Date:  2005-06       Impact factor: 4.005

3.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

4.  A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.

Authors:  Gisela Pachón-Peña; Conor Donnelly; Catalina Ruiz-Cañada; Adam Katz; Sonia Fernández-Veledo; Joan Vendrell; Robert Sackstein
Journal:  Stem Cells       Date:  2017-02-05       Impact factor: 6.277

5.  Expression of smooth muscle actin in osteoblasts in human bone.

Authors:  B Kinner; M Spector
Journal:  J Orthop Res       Date:  2002-05       Impact factor: 3.494

6.  Cutaneous osteomas: a clinical and histopathologic review.

Authors:  W Burgdorf; T Nasemann
Journal:  Arch Dermatol Res       Date:  1977-12-12       Impact factor: 3.017

7.  The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

Authors:  F S Kaplan; J A Tabas; F H Gannon; G Finkel; G V Hahn; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

8.  Cyclic AMP signaling in bone marrow stromal cells has reciprocal effects on the ability of mesenchymal stem cells to differentiate into mature osteoblasts versus mature adipocytes.

Authors:  Richard Kao; Weidar Lu; Alyssa Louie; Robert Nissenson
Journal:  Endocrine       Date:  2012-06-14       Impact factor: 3.633

9.  Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) Regulates the Expression of B-Cell Lymphoma/Leukemia-2 (Bcl-2) and Promotes the Survival of Mesenchymal Stem Cells (MSCs) via PGC-1α/ERRα Interaction in the Absence of Serum, Hypoxia, and High Glucose Conditions.

Authors:  Min Wang; Guangxin Yang; Xiaoyan Jiang; Debin Lu; Hao Mei; Bing Chen
Journal:  Med Sci Monit       Date:  2017-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.